Ge, M., Fang, Yy., Liu, Gp. et al. Effect of Shengmai injection (生脉注射液) on diaphragmatic contractility in doxorubicin-treated rats., Chin. J. Integr. Med. 20, 43–48 (2014). https://doi.org/10.1007/s11655-012-1096-9
Min Ge, Ying-yan Fang, Guo-ping Liu, et al. Effect of Shengmai injection (生脉注射液) on diaphragmatic contractility in doxorubicin-treated rats[J]. Chinese Journal of Integrative Medicine, 2014,20(1):43-48.
Ge, M., Fang, Yy., Liu, Gp. et al. Effect of Shengmai injection (生脉注射液) on diaphragmatic contractility in doxorubicin-treated rats., Chin. J. Integr. Med. 20, 43–48 (2014). https://doi.org/10.1007/s11655-012-1096-9DOI:
Min Ge, Ying-yan Fang, Guo-ping Liu, et al. Effect of Shengmai injection (生脉注射液) on diaphragmatic contractility in doxorubicin-treated rats[J]. Chinese Journal of Integrative Medicine, 2014,20(1):43-48. DOI: 10.1007/s11655-012-1096-9.
Effect of Shengmai injection (生脉注射液) on diaphragmatic contractility in doxorubicin-treated rats
摘要
To explore the diaphragmatic toxicity in doxorubicin (DOX)-treated rats and the related mechanisms
as well as the effects of Shengmai Injection (SMI
生脉注射液) on the diaphragmatic dysfunction. Thirty Sprague-Dawley male rats were randomly divided into three groups: control
DOX-treated and DOX+SMI treated groups. DOX was given to rats in DOX and DOX+SMI groups in 6 equal doses [2.5 mg/kg
intraperitoneal injection (i.p.)]
on alternate days
over a period of 2 weeks for a cumulative dose of 15 mg/kg. SMI was given to DOX+SMI rats in 12 doses (3 mL/kg
i.p.) for a period of 2 weeks before the administration of DOX and 2 weeks during the administration of DOX. The rats in the control group received equal volume of normal saline. Subsequently
the twitch and tetanic characteristics and force-frequency relationships
and the malondialdehyde (MDA) levels and the superoxide dismutase (SOD) activities
as well as the mRNA content and proteins of inducible nitric oxide synthase (iNOS) were determined. The DOX-treated rats had decreased the peak twitch tension (Pt)
maximal tetanic tension (P0) and force-frequency relationship as compared with the control rats (P<0.01)
while the diaphragm contractility in rats treated with SMI were significantly higher than that in DOX-treated rats (P<0.01). The DOX-treated rats had increased MAD levels and decreased SOD activities (P<0.05)
and SMI decreased the MDA levels and increased the SOD activities in DOX-treated rats (P<0.05). Ultrastructure of diaphragm in the DOX-treated rats revealed typical alterations including fracture of diaphragm fibers
and edema and degeneration of mitochondria; these changes were relieved by SMI treatment. The mRNA content and protein of iNOS in DOX-treated rats were remarkably higher than those in control rats (P<0.01)
while SMI decreased the mRNA expression level of iNOS in DOX-treated rats (P<0.05). Lipid peroxidation is responsible for DOX-induced diaphragm toxicity. SMI protects diaphragm muscles and their function from DOX impairment
and these beneficial effects may be somehow correlated with the decrease in expression of iNOS and lipid peroxidation.
Abstract
To explore the diaphragmatic toxicity in doxorubicin (DOX)-treated rats and the related mechanisms
as well as the effects of Shengmai Injection (SMI
生脉注射液) on the diaphragmatic dysfunction. Thirty Sprague-Dawley male rats were randomly divided into three groups: control
DOX-treated and DOX+SMI treated groups. DOX was given to rats in DOX and DOX+SMI groups in 6 equal doses [2.5 mg/kg
intraperitoneal injection (i.p.)]
on alternate days
over a period of 2 weeks for a cumulative dose of 15 mg/kg. SMI was given to DOX+SMI rats in 12 doses (3 mL/kg
i.p.) for a period of 2 weeks before the administration of DOX and 2 weeks during the administration of DOX. The rats in the control group received equal volume of normal saline. Subsequently
the twitch and tetanic characteristics and force-frequency relationships
and the malondialdehyde (MDA) levels and the superoxide dismutase (SOD) activities
as well as the mRNA content and proteins of inducible nitric oxide synthase (iNOS) were determined. The DOX-treated rats had decreased the peak twitch tension (Pt)
maximal tetanic tension (P0) and force-frequency relationship as compared with the control rats (P<0.01)
while the diaphragm contractility in rats treated with SMI were significantly higher than that in DOX-treated rats (P<0.01). The DOX-treated rats had increased MAD levels and decreased SOD activities (P<0.05)
and SMI decreased the MDA levels and increased the SOD activities in DOX-treated rats (P<0.05). Ultrastructure of diaphragm in the DOX-treated rats revealed typical alterations including fracture of diaphragm fibers
and edema and degeneration of mitochondria; these changes were relieved by SMI treatment. The mRNA content and protein of iNOS in DOX-treated rats were remarkably higher than those in control rats (P<0.01)
while SMI decreased the mRNA expression level of iNOS in DOX-treated rats (P<0.05). Lipid peroxidation is responsible for DOX-induced diaphragm toxicity. SMI protects diaphragm muscles and their function from DOX impairment
and these beneficial effects may be somehow correlated with the decrease in expression of iNOS and lipid peroxidation.
Minotti G, Menna P, Salvatorelli E, Cairo G, Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 2004;56:185–229.
Doroshow JH, Tallent C, Schechter JE. Ultrastructural features of adriamycin-induced skeletal and cardiac muscle toxicity. Am J Pathol 1985;118:288–297.
Singal PK, Iliskovic N. Doxorubicin induced cardiomyopathy. N Engl J Med 1998;339:900–905.
Wu S, Ko YS, Teng MS, Ko YL, Hsu LA, Hsueh C, et al. Adriamycin-induced cardiomyocyte and endothelial cell apoptosis: in vitro and in vivo studies. J Mol Cell Cardiol 2002;34:1595–1607.
Kalyanaraman B, Joseph J, Kalivendi S, Wang S, Konorev E, Kotamraju S. Doxorubicin-induced apoptosis: implications in cardiotoxicity. Mol Cell Biochem 2002;234:119–124.
Liu BG, Li HL, Qu HY, Sun BG. Nitric oxide synthase expressions in ADR-induced cardiomyopathy in rats. J Biochem Molr Biol 2006;39:759–765.
Liu XJ, Liu Y, Zhong CX, Hu CH. Protective effect of Shengmai injection on myocardial cells injured by adriamycin. China Healthcare Frontiers (Chin) 2009;4:7–8.
You JS, Huang HF, Chang YL, Lee YS. Shengmai-San reduces adriamycin-induced cardiomyopathy in rats. Am J Chin Med 2006;34:295–305.
Siveski Y, Iliskovic N, Kaul N, Singal PK. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation 1994;89:2829–2835.
Heunks LM, Machiels HA, Abreu R de, Zhu XP, van der Heijden HF, Dekhuijzen PN. Free radicals in hypoxic rat diaphragm contractility: no role for xanthine oxidase. Am J Physiol Lung Cell Mol 2001;281:1402–1412.
Takimoto Y, Aoyama T, Tanaka K, Keyamura R, Yui Y, Sasayama S. Augmented expression of neuronal nitric oxide synthase in the atria parasympathetically decreases heart rate during acute myocardial infarction in rats. Circulation 2002;105:490–496.
Morrison RJ, Miller CC, Reid MB. Nitric oxide effects on shortening velocity and power production in the rat diaphragm. J Appl Physiol 1996;80:1065–1069.
Chattopadhyay A, Bandyopadhyay D. Vitamin E in the prevention of ischemic heart disease. Pharmacol Rep 2006;58:179–187.
De Beer EL, Bottone AE, Voest EE. Doxorubicin and mechanical performance of cardiac trabeculae after acute and chronic treatment — a review. Eur J Pharmacol 2001;415:1–11.
Yao HT, Chang YW, Chen CT, Chiang MT, Chang L, Yeh TK. Shengmai San reduces hepatic lipids and lipid peroxidation in rats fed on a high-cholesterol diet. J Ethnopharmacol 2008;116:49–57.
Metabolic regulatory and anti-oxidative effects of modified bushen huoxue decoction (补肾活血方) on experimental rabbit model of osteoarthritis
Divergent immunomodulatory effects of extracts and phenolic compounds from the fern Osmunda japonica Thunb.
Anti-Inflammatory mechanism of total glycosides of Acanthopanax Giraldii
Effect of Shengmai injection (生脉注射液) on vascular endothelial and heart functions in patients with coronary heart disease complicated with diabetes mellitus
相关作者
暂无数据
相关机构
Department of Hematology, the Affiliated Hospital of Guiyang Medical College
Key Laboratory of Basic Pharmacology of Guizhou and Department of Pharmacology, Zunyi Medical College
Tianjin University of Traditional Chinese Medicine
The First Teaching Hospital of Tianjin University of Traditional Chinese Medicine
Institute of Pharmacology and Toxicology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic